Published in PLoS One on November 23, 2011
3D Slicer as an image computing platform for the Quantitative Imaging Network. Magn Reson Imaging (2012) 6.36
Registration accuracy and quality of real-life images. PLoS One (2012) 0.85
In vivo validation and 3D visualization of broadband ultrasound molecular imaging. Am J Nucl Med Mol Imaging (2013) 0.82
A Practical Approach Based on Analytic Deformable Algorithm for Scenic Image Registration. PLoS One (2013) 0.79
Creation and characterization of an ultrasound and CT phantom for noninvasive ultrasound thermometry calibration. IEEE Trans Biomed Eng (2013) 0.77
Segmentation of neuronal structures using SARSA (λ)-based boundary amendment with reinforced gradient-descent curve shape fitting. PLoS One (2014) 0.75
Dedicated breast CT: radiation dose and image quality evaluation. Radiology (2001) 4.43
MR thermometry. J Magn Reson Imaging (2008) 4.43
Abdominal fat: standardized technique for measurement at CT. Radiology (1999) 4.25
Comprehensive compilation of empirical ultrasonic properties of mammalian tissues. J Acoust Soc Am (1978) 3.96
Assessment of abdominal fat content by computed tomography. Am J Clin Nutr (1982) 3.22
Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size. Cancer Res (2000) 3.10
A new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model. Cancer Res (2000) 2.99
The distribution of target registration error in rigid-body point-based registration. IEEE Trans Med Imaging (2001) 2.74
Effect of local hyperthermia on blood flow and microenvironment: a review. Cancer Res (1984) 2.41
Pulsed-high intensity focused ultrasound and low temperature-sensitive liposomes for enhanced targeted drug delivery and antitumor effect. Clin Cancer Res (2007) 2.17
Rapid calibration for 3-D freehand ultrasound. Ultrasound Med Biol (1998) 1.85
Cellular responses to combinations of hyperthermia and radiation. Radiology (1977) 1.85
Two-dimensional temperature estimation using diagnostic ultrasound. IEEE Trans Ultrason Ferroelectr Freq Control (1998) 1.83
Frequency dependence of ultrasound attenuation and backscatter in breast tissue. Ultrasound Med Biol (1986) 1.79
Noise power properties of a cone-beam CT system for breast cancer detection. Med Phys (2008) 1.48
Classification of breast computed tomography data. Med Phys (2008) 1.29
Radiation therapy and hyperthermia improve the oxygenation of human soft tissue sarcomas. Cancer Res (1996) 1.28
A review of calibration techniques for freehand 3-D ultrasound systems. Ultrasound Med Biol (2005) 1.26
Three-dimensional C-arm cone-beam CT: applications in the interventional suite. J Vasc Interv Radiol (2009) 1.16
Spatial and temporal-controlled tissue heating on a modified clinical ultrasound scanner for generating mild hyperthermia in tumors. IEEE Trans Biomed Eng (2010) 1.12
Soft tissue elastometer. Med Eng Phys (2007) 1.06
Effectiveness of real-time virtual sonography-guided radiofrequency ablation treatment for patients with hepatocellular carcinomas. Hepatol Res (2008) 1.03
Noninvasive thermometry assisted by a dual-function ultrasound transducer for mild hyperthermia. IEEE Trans Ultrason Ferroelectr Freq Control (2010) 1.01
The effects of hyperthermia on vascular permeability in experimental liver metastasis. J Surg Oncol (1985) 0.92
Noninvasive temperature estimation using sonographic digital images. J Ultrasound Med (2007) 0.91
Ultrasonic attenuation in human tissue. Ultrasound Med Biol (1975) 0.90
Real-time virtual ultrasonographic radiofrequency ablation of renal cell carcinoma. BJU Int (2008) 0.84
A scanned, focused, multiple transducer ultrasonic system for localized hyperthermia treatments. Int J Hyperthermia (1987) 0.79
The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell (2005) 5.81
MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature (2004) 5.61
Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis. Nat Genet (2009) 5.31
PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms. Cancer Cell (2003) 5.13
Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice. Blood (2002) 4.88
Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis. Cancer Cell (2002) 4.36
Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer Cell (2006) 4.15
Dedicated breast CT: initial clinical experience. Radiology (2008) 3.70
Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis. Cell (2005) 3.68
Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis. Proc Natl Acad Sci U S A (2003) 3.61
Classification of proliferative pulmonary lesions of the mouse: recommendations of the mouse models of human cancers consortium. Cancer Res (2004) 3.43
CT dose index and patient dose: they are not the same thing. Radiology (2011) 3.38
Lineage analysis of basal epithelial cells reveals their unexpected plasticity and supports a cell-of-origin model for prostate cancer heterogeneity. Nat Cell Biol (2013) 2.90
Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis. Proc Natl Acad Sci U S A (2002) 2.89
Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion. Cancer Res (2004) 2.84
Mammary epithelial-specific disruption of the focal adhesion kinase blocks mammary tumor progression. Proc Natl Acad Sci U S A (2007) 2.64
Contrast-enhanced dedicated breast CT: initial clinical experience. Radiology (2010) 2.58
Syngeneic mouse mammary carcinoma cell lines: two closely related cell lines with divergent metastatic behavior. Clin Exp Metastasis (2005) 2.52
Prostatic intraepithelial neoplasia in genetically engineered mice. Am J Pathol (2002) 2.48
Insights from transgenic mouse models of ERBB2-induced breast cancer. Nat Rev Cancer (2007) 2.41
The magnitude of radiation force on ultrasound contrast agents. J Acoust Soc Am (2002) 2.38
Nkx3.1 mutant mice recapitulate early stages of prostate carcinogenesis. Cancer Res (2002) 2.29
Impact of p53 loss on reversal and recurrence of conditional Wnt-induced tumorigenesis. Genes Dev (2003) 2.27
Ultrasound contrast microbubbles in imaging and therapy: physical principles and engineering. Phys Med Biol (2009) 2.27
Pathway pathology: histological differences between ErbB/Ras and Wnt pathway transgenic mammary tumors. Am J Pathol (2002) 2.26
Dissociation of epithelial and neuroendocrine carcinoma lineages in the transgenic adenocarcinoma of mouse prostate model of prostate cancer. Am J Pathol (2007) 2.23
Radiation-force assisted targeting facilitates ultrasonic molecular imaging. Mol Imaging (2004) 2.19
Nkx3.1; Pten mutant mice develop invasive prostate adenocarcinoma and lymph node metastases. Cancer Res (2003) 2.11
Direct observations of ultrasound microbubble contrast agent interaction with the microvessel wall. J Acoust Soc Am (2007) 2.11
Developmental context determines latency of MYC-induced tumorigenesis. PLoS Biol (2004) 2.05
Evaluation of the spatial resolution characteristics of a cone-beam breast CT scanner. Med Phys (2007) 2.02
Met induces mammary tumors with diverse histologies and is associated with poor outcome and human basal breast cancer. Proc Natl Acad Sci U S A (2009) 2.01
Acoustic response of compliable microvessels containing ultrasound contrast agents. Phys Med Biol (2006) 1.91
Targeted imaging using ultrasound. J Magn Reson Imaging (2002) 1.88
Siah2-dependent concerted activity of HIF and FoxA2 regulates formation of neuroendocrine phenotype and neuroendocrine prostate tumors. Cancer Cell (2010) 1.88
A geometric calibration method for cone beam CT systems. Med Phys (2006) 1.87
Enhancement of vascular permeability with low-frequency contrast-enhanced ultrasound in the chorioallantoic membrane model. Radiology (2007) 1.86
ShcA signalling is essential for tumour progression in mouse models of human breast cancer. EMBO J (2008) 1.82
A method for radiation-force localized drug delivery using gas-filled lipospheres. IEEE Trans Ultrason Ferroelectr Freq Control (2004) 1.79
Motion corrected cadence CPS ultrasound for quantifying response to vasoactive drugs in a rat kidney model. Urology (2009) 1.78
Influence of lipid shell physicochemical properties on ultrasound-induced microbubble destruction. IEEE Trans Ultrason Ferroelectr Freq Control (2005) 1.77
Therapeutic effects of paclitaxel-containing ultrasound contrast agents. Ultrasound Med Biol (2006) 1.75
Ductal carcinoma in situ: state of the science and roadmap to advance the field. J Clin Oncol (2008) 1.74
Acoustically-active microbubbles conjugated to liposomes: characterization of a proposed drug delivery vehicle. J Control Release (2006) 1.70
Initial characterization of a dedicated breast PET/CT scanner during human imaging. J Nucl Med (2009) 1.68
Ultrasound radiation force enables targeted deposition of model drug carriers loaded on microbubbles. J Control Release (2005) 1.68
Somatic mutation of p53 leads to estrogen receptor alpha-positive and -negative mouse mammary tumors with high frequency of metastasis. Cancer Res (2004) 1.67
Characterizing anatomical variability in breast CT images. Med Phys (2008) 1.67
Epoxy metabolites of docosahexaenoic acid (DHA) inhibit angiogenesis, tumor growth, and metastasis. Proc Natl Acad Sci U S A (2013) 1.66
Evaluation of x-ray scatter properties in a dedicated cone-beam breast CT scanner. Med Phys (2005) 1.66
Animal models of human prostate cancer: the consensus report of the New York meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee. Cancer Res (2013) 1.66
Ultrasound molecular imaging of tumor angiogenesis with an integrin targeted microbubble contrast agent. Invest Radiol (2011) 1.64
Methodology for generating a 3D computerized breast phantom from empirical data. Med Phys (2009) 1.64
Long-circulating liposomes radiolabeled with [18F]fluorodipalmitin ([18F]FDP). Nucl Med Biol (2007) 1.60
Enhanced in vivo bioluminescence imaging using liposomal luciferin delivery system. J Control Release (2009) 1.60
Maternal dioxin exposure combined with a diet high in fat increases mammary cancer incidence in mice. Environ Health Perspect (2010) 1.60
Suppression of the negative regulator LRIG1 contributes to ErbB2 overexpression in breast cancer. Cancer Res (2008) 1.59
PPAR gamma signaling exacerbates mammary gland tumor development. Genes Dev (2004) 1.58
STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas. Breast Cancer Res (2012) 1.56
T-cadherin supports angiogenesis and adiponectin association with the vasculature in a mouse mammary tumor model. Cancer Res (2008) 1.54
Effects of FVB/NJ and C57Bl/6J strain backgrounds on mammary tumor phenotype in inducible nitric oxide synthase deficient mice. Transgenic Res (2007) 1.54
Determination of height, weight, body mass index, and body surface area with a single abdominal CT image. Radiology (2003) 1.53
SLITs suppress tumor growth in vivo by silencing Sdf1/Cxcr4 within breast epithelium. Cancer Res (2008) 1.52
Luminal expression of PIK3CA mutant H1047R in the mammary gland induces heterogeneous tumors. Cancer Res (2011) 1.52
Lateral phase separation in lipid-coated microbubbles. Langmuir (2006) 1.52
E mu-BRD2 transgenic mice develop B-cell lymphoma and leukemia. Blood (2003) 1.51
Kinase-inactive glycogen synthase kinase 3beta promotes Wnt signaling and mammary tumorigenesis. Cancer Res (2005) 1.50
Ultrasonic analysis of peptide- and antibody-targeted microbubble contrast agents for molecular imaging of alphavbeta3-expressing cells. Mol Imaging (2004) 1.49
Quantitative imaging test approval and biomarker qualification: interrelated but distinct activities. Radiology (2011) 1.48
Noise power properties of a cone-beam CT system for breast cancer detection. Med Phys (2008) 1.48
EMT tumorigenesis in the mouse mammary gland. Lab Invest (2007) 1.47
A critical role for p27kip1 gene dosage in a mouse model of prostate carcinogenesis. Proc Natl Acad Sci U S A (2004) 1.47
The effect of skin thickness determined using breast CT on mammographic dosimetry. Med Phys (2008) 1.46
Targeted imaging using ultrasound contrast agents. Progess and opportunities for clinical and research applications. IEEE Eng Med Biol Mag (2004) 1.46
Activation of beta -catenin signaling in differentiated mammary secretory cells induces transdifferentiation into epidermis and squamous metaplasias. Proc Natl Acad Sci U S A (2002) 1.44
Activation of different Wnt/beta-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors. Oncogene (2002) 1.43
ANCCA/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2. Cancer Res (2010) 1.43
Ets2-dependent stromal regulation of mouse mammary tumors. Mol Cell Biol (2003) 1.43
Application of ultrasound to selectively localize nanodroplets for targeted imaging and therapy. Mol Imaging (2006) 1.43
The characterization of breast anatomical metrics using dedicated breast CT. Med Phys (2011) 1.42
Rapamycin inhibits growth of premalignant and malignant mammary lesions in a mouse model of ductal carcinoma in situ. Clin Cancer Res (2006) 1.39
A novel method to label preformed liposomes with 64Cu for positron emission tomography (PET) imaging. Bioconjug Chem (2008) 1.39
Contrast-enhanced US of microcirculation of superficially implanted tumors in rats. Radiology (2003) 1.38
Activation of beta-catenin in prostate epithelium induces hyperplasias and squamous transdifferentiation. Oncogene (2003) 1.37
In vivo positron-emission tomography imaging of progression and transformation in a mouse model of mammary neoplasia. Proc Natl Acad Sci U S A (2004) 1.37
Mouse mammary tumor virus c-rel transgenic mice develop mammary tumors. Mol Cell Biol (2003) 1.36
Tumor escape in a Wnt1-dependent mouse breast cancer model is enabled by p19Arf/p53 pathway lesions but not p16 Ink4a loss. J Clin Invest (2008) 1.36
Imaging of angiogenesis using Cadence contrast pulse sequencing and targeted contrast agents. Contrast Media Mol Imaging (2008) 1.34
Oncogenic signaling pathways activated in DMBA-induced mouse mammary tumors. Toxicol Pathol (2005) 1.34
Polyomavirus middle T-induced mammary intraepithelial neoplasia outgrowths: single origin, divergent evolution, and multiple outcomes. Mol Cancer Ther (2004) 1.33
From whence will they come? - A perspective on the acute shortage of pathologists in biomedical research. J Vet Diagn Invest (2007) 1.32
HER2/neu-induced mammary tumorigenesis and angiogenesis are reduced in cyclooxygenase-2 knockout mice. Cancer Res (2005) 1.32
Dynamics of therapeutic ultrasound contrast agents. Ultrasound Med Biol (2002) 1.32
Computer modeling of the spatial resolution properties of a dedicated breast CT system. Med Phys (2007) 1.31